PARIS -- (BUSINESS WIRE) -- France Biotech, (www.france-biotech.org), an association of entrepreneurs in the life sciences industry, today announced the launch of its website (http://conf.france-biotech.org/france-biotech/french-conf) dedicated to the first annual “French Life Sciences Days,” which will be held in New York on June 25th and 26th. To date, over 50 U.S. investors are registered to attend the event.
This website will showcase “French Life Sciences Days,” and will provide background information on the partners and 19 companies joining the event. Video interviews with the CEOs and partners, as well as fact sheets will be available. This platform will allow the partners and companies to highlight their areas of expertise and will provide important insights to site visitors, including members of the North American financial community.
“France Biotech is providing the French-American life sciences ecosystem with a tool to reinforce the dialogue and links between publicly-traded French life sciences companies and members of the U.S. financial community in advance of the first annual “French Life Sciences Days”. This first annual will welcome the most renowned North American investment funds specializing in the life sciences over two days. The strong interest in the event shows a tremendous interest in our industry in the U.S.” stated Pierre-Olivier GOINEAU, President of France Biotech.
About the “French Life Sciences Days”
This new initiative by France Biotech aims at fostering and boosting the connections between French public companies and investors worldwide in an effort to facilitate exchanges and demonstrate the solidity of our own financial community. The first edition will be held in New York. This “French Life Sciences Days” initiative brings together key Parisian players (banks, brokers, analysts, auditors, lawyers and communication agencies) to form a sponsorship committee that will support entrepreneurs in the life sciences. During this occasion, the French biotech and medtech companies listed on the NYSE Euronext exchange will introduce themselves to international investors.
About France Biotech
France Biotech brings together the main French life science companies and their expert partners. Its mission is to support the development of the French life sciences by advocating for a favorable regulatory and fiscal environment. In 2004, France Biotech successfully lobbied the French government to create a special fiscal status for innovative start-ups and continues to act as an advocate for the French innovative sector. The organization is currently chaired by Pierre-Olivier Goineau, Co-Founder and CEO of ERYTECH Pharma. France Biotech has over 150 members and its board of directors is composed of 20 entrepreneurs in the life sciences.